Patents by Inventor Ronald Smith

Ronald Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11548888
    Abstract: The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: January 10, 2023
    Assignees: Mirati Therapeutics, Inc., Array BioPharma Inc.
    Inventors: Matthew Arnold Marx, James Gail Christensen, Christopher Ronald Smith, John P Fischer, Aaron Craig Burns
  • Patent number: 11492351
    Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds of Formula (I) to pharmaceutical compositions comprising compounds of Formula (I) and to methods of use thereof, such as methods of treating cancer using the compounds of Formula (I) and pharmaceutical compositions comprising those compounds.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: November 8, 2022
    Assignee: Mirati Therapeutics, Inc.
    Inventors: Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson, Svitlana Kulyk, Jon Kuehler, Anthony Ivetac
  • Patent number: 11479551
    Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds of Formula (I) to pharmaceutical compositions comprising compounds of Formula (I) and to methods of use thereof, such as methods of treating cancer using the compounds of Formula (I) and pharmaceutical compositions comprising those compounds.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: October 25, 2022
    Assignee: Mirati Therapeutics, Inc.
    Inventors: Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson, Svitlana Kulyk, Jon Kuehler, Anthony Ivetac
  • Patent number: 11453683
    Abstract: Compounds that inhibit KRas G12D; in particular, compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor, and in particular, methods of treating cancer. The compounds have a general structure represented by Formula (I): or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: September 27, 2022
    Assignees: MIRATI THERAPEUTICS, INC., ARRAY BIOPHARMA INC.
    Inventors: Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson, Matthew Arnold Marx, Christopher Ronald Smith, Shelley Allen, James F. Blake, Mark Joseph Chicarelli, Joshua Ryan Dahlke, Donghua Dai, Jay Bradford Fell, John Peter Fischer, Macedonio J. Mejia, Brad Newhouse, Phong Nguyen, Jacob Matthew O'Leary, Spencer Pajk, Martha E. Rodriguez, Pavel Savechenkov, Tony P. Tang, Guy P. A. Vigers, Qian Zhao, Dean Russell Kahn, John Gaudino, Michael Christopher Hilton
  • Patent number: 11423391
    Abstract: An electronic device may include circuitry and an anti-tamper device having a physical characteristic that changes in response to a tamper attempt. The circuitry is configured to determine physically unclonable function (PUF) data based on the physical characteristic and to perform at least one secure operation based on the PUF data. The circuitry is further configured to detect the tamper attempt based a change to the physical characteristic and to perform at least one action in response to detection of the tamper attempt for protecting the electronic device from the tamper attempt.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: August 23, 2022
    Assignee: Block, Inc.
    Inventors: Jeremy Wade, William Hardy, Malcolm Ronald Smith, Afshin Rezayee, Yue Yang
  • Publication number: 20220211129
    Abstract: A glove of a type worn to provide masking effect between a wear's hand and another surface, such as surface of food stuff. The glove, or fragments thereof, is rendered detectable by X-ray and/or metal detection apparatus. Apparatus and/or indication means can be provided to allow a detected glove or glove portion to be allocated to a particular location and/or personnel to allow, if necessary, remedial action to be taken.
    Type: Application
    Filed: September 18, 2020
    Publication date: July 7, 2022
    Inventor: Sean Ronald SMITH
  • Publication number: 20220194961
    Abstract: The present invention relates to compounds that inhibit at least one of KRas wild type, KRas G12A, KRas G12C, KRas G12D, KRas G12R, KRas G12S, KRas G12V, KRas G13D and KRas Q61H, pharmaceutical compositions comprising the compounds and methods of use therefor.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Inventors: Xiaolun Wang, Anthony Ivetac, Svitlana Kulyk, John David Lawson, Matthew Arnold Marx, Christopher Ronald Smith
  • Publication number: 20220161592
    Abstract: The invention relates to a writing implement such as a pen which includes a housing and an internal component in which there is provided a reservoir of ink. The internal component typically includes a portion such as a ballpoint which allows ink to be transferred from the reservoir to a surface to which the said portion is applied. The writing implement and/or internal component is rendered detectable by metal detection and/or X-ray detection apparatus when the internal component is within range of the same so that the internal component is detectable when separated, deliberately or inadvertently, from the remainder of the writing implement.
    Type: Application
    Filed: March 16, 2020
    Publication date: May 26, 2022
    Inventor: Sean Ronald Smith
  • Publication number: 20210394962
    Abstract: This invention is a portable beverage cooler that dispenses two kinds of beverages within the same cooler. This is possible by dividing the cooler in the middle with a single partition to separate the two beverages. Both sides have a separate and detachable lid for adding the desired beverage. It is designed as a tall rectangle shape with handles to make it easy to carry to a location and transport from a vehicle. Durable plastic for the product material is used to keep the container weight light enough to carry. The beverage cooler is propped up at waist high onto a table for easy access. Each side of the cooler has a valve to dispense the beverage. A cup is placed below the valve to release the desired beverage into the cup. Lids can be removed separately to confine the beverage to the section, when more beverage is added to the cooler and for easy access.
    Type: Application
    Filed: May 14, 2021
    Publication date: December 23, 2021
    Inventor: Ronald Smith
  • Patent number: 11187591
    Abstract: The invention relates to the provision of apparatus for use in measuring the temperature of a body of matter and in particular the temperature of a foodstuff in a manner which allows the required apparatus in the form of a housing with data processing means and a temperature probe connected thereto, to be used effectively and without the apparatus itself becoming a safety hazard. This is achieved by using materials which are provided in a form to allow the apparatus, and portions thereof to be rendered detectable by metal detection and/or X-ray detection apparatus.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: November 30, 2021
    Inventor: Sean Ronald Smith
  • Publication number: 20210330516
    Abstract: Described herein are apparatus, methods, and systems for detecting the presence of a targeted substance. The apparatus comprises a detection layer comprising an indicator that is configured to display a signal upon the detection of an interaction with the targeted substance. In some examples, the apparatus can include a top layer coupled to a top surface of the detection layer and a bottom layer coupled to a bottom surface of the detection layer.
    Type: Application
    Filed: January 27, 2017
    Publication date: October 28, 2021
    Inventors: Nicolas Letourneau, Aly Khalifa, Michael Gorczynski, Catherina Gomes, Ronald Smith, Sarah Paluskiewicz, Stephen Gray, Tyler Confrey-Maloney
  • Patent number: 11149614
    Abstract: Methods and systems are provided for controlling a vehicle engine to adjust exhaust warm-up strategy based on a vehicle network information. In one example, in response to an expected decrease in temperature of a catalyst of a vehicle below a threshold and an estimated duration thereof based on communications external from the vehicle, a method may include delaying catalyst heating actions, when the catalyst heating actions are determined to be unable to heat up the catalyst to threshold temperatures. However, the catalyst heating actions may be enabled when the catalyst heating actions are determined to be able to achieve the threshold temperature within the duration.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: October 19, 2021
    Assignee: Ford Global Technologies, LLC
    Inventors: Jason Ronald Smith, Michael Brendan Hopka, Devesh Upadhyay
  • Patent number: 11147478
    Abstract: A patient monitor is disclosed for detecting patient movement or abnormal breathing. Images of a patient are obtained by a stereoscopic camera. These images are then processed by a 3D position determination module which determines measurements indicative of positions of at least part of a patient. The obtained measurements are then passed to a model generation module which generates a breathing model of the variation in position of the at least part of a patient during a breathing cycle. Subsequently abnormal breathing or patient movement can be detected by processing further images obtained by the stereoscopic camera to determine more measurements indicative of positions of at least part of a patient. These measurements are then compared with a stored breathing model by a comparison module.
    Type: Grant
    Filed: November 20, 2018
    Date of Patent: October 19, 2021
    Assignee: VISION RT LIMITED
    Inventors: Ivan Daniel Meir, Norman Ronald Smith, Anthony Christopher Ruto
  • Publication number: 20210221584
    Abstract: The invention to which this application relates to improvements to a retaining band which can be used to securely locate, form and retain a load of items or goods, in one embodiment on a pallet, and thereby retain the said items or goods as a single integral package. The invention allows for the adaptation of the retaining bands to be detectable when with a predetermined range of detection apparatus such as X-ray and/or metal detection apparatus so that should the retaining band or fragments thereof be discarded or dislodged, the presence of the same is detectable and therefore prevented from becoming a potential contaminant or safety hazard.
    Type: Application
    Filed: January 15, 2021
    Publication date: July 22, 2021
    Inventor: Sean Ronald Smith
  • Patent number: 11065077
    Abstract: Mechanical optics for mode mixing may be used to homogenize different modes in an optical fiber used for surgical illumination. A mechanical optical element, such as a rotating prism or a mirror membrane, may impart motion to an incident beam entering the optical fiber to generate a homogeneous illumination field from a coherent light source.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: July 20, 2021
    Assignee: Alcon Inc.
    Inventors: Cesario Dos Santos, Gerald David Bacher, Ronald Smith, Alireza Mirsepassi, Michael Papac
  • Publication number: 20210188857
    Abstract: The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
    Type: Application
    Filed: December 18, 2020
    Publication date: June 24, 2021
    Inventors: Matthew Arnold Marx, John Michael Ketcham, Christopher Ronald Smith, John David Lawson, Aaron Craig Burns, Xiaolun Wang, Svitlana Kulyk, Anthony Ivetac
  • Patent number: 11006822
    Abstract: Pixelated array optics for mode mixing may be used to homogenize different modes in an optical fiber used for surgical illumination. A pixelated phase array, such as a digital micromirror device or an LCD phase plate, may impart motion to an incident beam entering the optical fiber to generate a homogeneous illumination field from a coherent light source.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: May 18, 2021
    Assignee: Alcon Inc.
    Inventors: Cesario Dos Santos, Gerald David Bacher, Ronald Smith, Alireza Mirsepassi, Michael Papac
  • Publication number: 20210085002
    Abstract: A glove of a form typically, although not necessarily exclusively, provided for single or limited use purposes and discarded thereafter. The glove is to prevent contact between a product and a person's hand and to avoid contamination. The glove material includes components capable of detection by at least one form of noncontact detection apparatus which renders the glove or portion detectable if discarded and inadvertently becomes part of a manufacturing process or product. The components render the glove detectable by using metal detection apparatus and/or X-ray detection apparatus which may allow removal of the glove. The glove may also include an antimicrobial agent as part to prevent or reduced contamination on the surface of the glove. The glove can also be rendered biodegradable.
    Type: Application
    Filed: November 14, 2019
    Publication date: March 25, 2021
    Inventor: Sean Ronald Smith
  • Publication number: 20210078994
    Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
    Type: Application
    Filed: September 11, 2020
    Publication date: March 18, 2021
    Inventors: Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson, Svitlana Kulyk, Jon Kuehler, Anthony Ivetac
  • Publication number: 20210079003
    Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
    Type: Application
    Filed: September 11, 2020
    Publication date: March 18, 2021
    Inventors: Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson, Svitlana Kulyk, Jon Kuehler, Anthony Ivetac